Table 3.
Female | Male | ||||
---|---|---|---|---|---|
LC | pOC-ERαKO | LC | pOC-ERαKO | ||
Cn.MS | Control | 0.210 ± 0.033bc | 0.231 ± 0.040c | 0.276 ± 0.046 | 0.250 ± 0.059 |
Loaded | 0.325 ± 0.041†ab | 0.279 ± 0.034†a | 0.320 ± 0.025† | 0.279 ± 0.086† | |
|
|||||
Cn.MAR (μm/day) | Control | 1.51 ± 0.14b | 1.18 ± 0.12*b | 1.09 ± 0.13 | 1.01 ± 0.53 |
Loaded | 1.85 ± 0.33†ab | 2.11 ± 0.31†a | 1.19 ± 0.18 | 1.10 ± 0.38 | |
|
|||||
Cn.BFR (yr−1) | Control | 0.0550 ± 0.017 | 0.0502 ± 0.017 | 0.0331 ± 0.016 | 0.0266 ± 0.018 |
Loaded | 0.0897 ± 0.041† | 0.0396 ± 0.014† | 0.0825 ± 0.014 | 0.0270 ± 0.013 | |
| |||||
Es.MS | Control | 0.587 ± 0.029 | 0.551 ± 0.186 | 0.357 ± 0.19 | 0.195 ± 0.12* |
Loaded | 0.556 ± 0.16 | 0.380 ± 0.10 | 0.312 ± 0.19† | 0.137 ± 0.059*† | |
|
|||||
Es.MAR (μm/day) | Control | 0.825 ± 0.19 | 0.710 ± 0.37 | 0.438 ± 0.37 | 0.320 ± 0.37 |
Loaded | 2.08 ± 0.57† | 1.47 ± 0.43† | 0.529 ± 0.72 | 0.143 ± 0.35 | |
|
|||||
Es.BFR (yr−1) | Control | 0.0669 ± 0.014b | 0.0605 ± 0.038*b | 0.0241 ± 0.017 | 0.0106 ± 0.015 |
Loaded | 0.198 ± 0.076†a | 0.105 ± 0.037*†a | 0.0323 ± 0.045 | 0.00282 ± 0.007 | |
|
|||||
Es.Wo.Ar (mm2) | Control | 0.00 ± 0.0 | 0.00 ± 0.0 | 0.00 ± 0.0 | 0.00 ± 0.0 |
Loaded | 0.0105 ± 0.015† | 0.0223 ± 0.014† | 0.00 ± 0.0 | 0.00 ± 0.0 | |
| |||||
Ps.MS | Control | 0.105 ± 0.060 | 0.0827 ± 0.032 | 0.0839 ± 0.045 | 0.211 ± 0.17 |
Loaded | 0.226 ± 0.081† | 0.260 ± 0.11† | 0.431 ± 0.23† | 0.413 ± 0.15† | |
|
|||||
Ps.MAR (μm/day) | Control | 0.00 ± 0.0 | 0.00 ± 0.0 | 0.00 ± 0.0 | 0.147 ± 0.36 |
Loaded | 2.34 ± 0.19† | 1.70 ± 0.91† | 1.02 ± 0.95† | 0.775 ± 0.48† | |
|
|||||
Ps.BFR (yr−1) | Control | 0.00 ± 0.0 | 0.00 ± 0.0 | 0.00 ± 0.0 | 0.00596 ± 0.015 |
Loaded | 0.0964 ± 0.019† | 0.0774 ± 0.040† | 0.0552 ± 0.053 | 0.0270 ± 0.019 | |
|
|||||
Ps.Wo.Ar (mm2) | Control | 0.00 ± 0.0 | 0.00 ± 0.0 | 0.00 ± 0.0 | 0.00 ± 0.0 |
Loaded | 0.140 ± 0.028† | 0.166 ± 0.049† | 0.00525 ± 0.012 | 0.00 ± 0.0 | |
| |||||
N.Ob/BS (mm−1) | Control | 2.48 ± 1.0 | 1.27 ± 0.23 | 1.68 ± 0.42 | 1.67 ± 0.41 |
Loaded | 3.02 ± 1.0† | 2.84 ± 0.69† | 2.77 ± 0.99† | 2.57 ± 0.48† | |
|
|||||
N.Oc/BS (mm−1) | Control | 2.48 ± 1.3 | 1.97 ± 0.98 | 2.90 ± 0.93 | 3.47 ± 0.91 |
Loaded | 2.41 ± 0.87 | 2.35 ± 0.91 | 3.85 ± 1.4† | 4.38 ± 0.66† | |
|
|||||
GP.Th (μm) | Control | 107 ± 8.5 | 119 ± 2.7* | 106 ± 15 | 119 ± 10 |
Loaded | 178 ± 5.0† | 198 ± 17*† | 187 ± 15† | 180 ± 34† |
Data are mean ± SD. Cn, cancellous; Es, endosteal; Ps, periosteal; MS, mineralizing surface; MAR, mineral apposition rate; BFR, bone formation rate; N.Ob/BS and N.Oc/BS, number of matrix-secreting osteoblasts positively-stained for procollagen 1 or positively-stained osteoclasts with TRAP normalized to bone surface; GP.Th, growth plate thickness
pOC-ERαKO different from LC,
Loaded tibia different from Control, p<0.05 by repeated measures ANOVA with interaction for each sex.
Groups not sharing the same letter are significantly different by Tukey HSD post-hoc where a > b > c. Post-hoc performed when ANOVA interaction term was significant.